Risk score

Large logo of OmniAb


Flag of United States of AmericaUnited States of America

The OmniAb exploration platform offers Ligand’s partners in the pharmaceutical sector the opportunity to access a wide range of antibody repertoires and advanced screening technologies to support the discovery of cutting-edge therapeutics. At the core of the OmniAb platform lies the Biological Intelligence™ (BI) of our unique transgenic animals, such as OmniRat, OmniChicken, and OmniMouse, which have been genetically engineered to produce antibodies containing human sequences, thus facilitating the development of human therapeutic candidates.